glp-1 compounded drug restriction

FDA moves to restrict compounded versions of popular GLP-1 weight loss drugs — Photo by Pew Nguyen on Pexels

Prescription Weight Loss Myth Exposed: Compounding Is Limited

Prescription Weight Loss Myth Exposed: Compounding Is Limited Compounded GLP-1 weight-loss drugs are not a safe, cheap alternative; they carry a 12% higher dosing error rate than FDA-approved brands. The FDA has now narrowed the situations where a pharmacy can bulk-compound semaglutide, tirzepatide or liraglutide, meaning patients will need a